Mitogen-activated protein kinase mediates purinergic-enhanced nerve growth factor-induced neurite outgrowth in PC12 cells

Journal of Neuroscience Research

Volumn 78, Issue 1, 2004, Pages 64-74

  Behrsing, Holger Peter ^a   Vulliet, P Richard ^b  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kinase; MAPK; Neurite outgrowth; NGF; Purinergic

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NERVE GROWTH FACTOR; PHOSPHORUS 32; PROTEIN KINASE C INHIBITOR; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; NEURITES; PC12 CELLS; RATS;

EID: 4644258653     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20236     Document Type: Article

References (45)

1. Barnard EA, Simon J, Webb TE. 1997. Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms. Mol Neurobiol 15:103-129.
2. Behrsing HP, Vulliet PR. 1999. Purinergic and calcium-mediated enhancement of NGF-induced neurite expression in PC12 cells. Proc West Pharmacol Soc 42:59-62.
3. Brake AJ, Julius D. 1996. Signaling by extracellular nucleotides. Annu Rev Cell Dev Biol 12:519-541.
4. Brake AJ, Wagenbach MJ, Julius D. 1994. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-523.
5. Burnstock G, Jacobsen KA. 2000. Pharmacological characterization of P2 (nucleotide) receptors. Cell Transmissions 16:3-16.
6. Calne DB. 1994. Neurodegenerative diseases. Philadelphia: W.U. Saunders Co. 992 p.
7. Campbell DC, Hardie DG, Vulliet PR. 1986. Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J Biol Chem 261:10489-10492.
8. Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F, Di Iorio P. 2001. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19:395-414.
9. D'Ambrosi N, Cavaliere F, Merlo D, Milazzo L, Mercanti D, Volonte C. 2000. Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology 39:1083-1094.
10. 32P|ATP in PC12 cells. Neurochem Int 19:581-592.
11. Fredholm BB. 1995. Purinoceptors in the nervous system. Pharmacol Toxicol 76:228-239.
12. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. 1994. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
13. Friedman WJ, Greene LA. 1999. Neurotrophin signaling via Trks and p75. Exp Cell Res 253:131-142.
14. Granholm AC. 2000. Oestrogen and nerve growth factor - neuroprotection and repair in Alzheimer's disease. Expert Opin Invest Drugs 9:685-694.
15. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73:2424-2428.
16. Hall FL, Fernyhough P, Ishii DN, Vulliet PR. 1988. Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C. J Biol Chem 263 9:4460-4466.
17. Harden TK, Boyer JL, Nicholas RA. 1995. P2-purinergic receptors: Subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35:541-579.
18. Illes P, Nieber K, Norenberg W. 1996. Electrophysiological effects of ATP on brain neurones. J Auton Phannacol 16:407-411.
19. Jaiswal RK, Weissinger E, Kolch W, Landreth GE. 1996. Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90. J Biol Chem 271:23626-23629.
20. Jonhagen ME. 2000. Nerve growth factor treatment in dementia. Alzheimer Dis Assoc Disord 14(Snppl 1):S31-S38.
21. Kaplan DR, Stephens RM. 1994. Neurotrophin signal transduction by the Trk receptor. Neurobiology 25:1404-1417.
22. Kittner H, Krugel U, Poelchen W, Sieler D, Reinhardt R, von Kugelgen I, Illes P. 1999. P2 receptor-mediated activation of noradrenergic and dopaminergic neurons in the rat brain. Prog Brain Res 120:223-235.
23. Klesse LJ, Parade LF. 1999. Trks: signal transduction and intracellular pathways. Microsc Res Techniq 45:210-216.
24. Kulp KS, Green SL, Vulliet PR. 1996. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp Cell Res 229:60-68.
25. Lad SP, Neet KE, Mufson EJ. 2003. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Target CNS Neurol Disord 2:215-234.
26. 2+-independent in PC12 cells. J Biol Chem 265:18055-18058.
27. 2+- independent phenomenon. Cell Biol 130:701-710.
28. Michel AD, Grahames CBA, Humphrey PPA. 1996. Functional characterization of P2 purinoreceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedebergs Arch Pharmacol 354: 562-571.
29. Mitchell JP, Hardie DG, Vulliet PK. 1990. Site-specific phosphorylation of tyrosine hydroxylase after KCl depolarization and nerve growth factor treatment of PC12 cells. J Biol Chem 265:22358-22364.
30. Morooka T, Nishida E. 1998. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 273:24285-24288.
31. Murayama T, Yakushi Y, Watanabe A, Nomura Y. 1998. P2 receptor-mediated inhibition of adenylyl cyclase in PC12 cells. Eur J Pharmacol 348:71-76.
32. Neary JT, McCarthy M, Cornell-Bell A, Kang Y. 1999. Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog Brain Res 120:323-332.
33. Obermeier A, Lammers R, Wiesmuller KH, Jung G, Schlessinger J, Ullrich A. 1993. Identification of Trk binding sites for SHC and phosphotidylinositol 3′-kinase and formation of a multimeric signaling complex. J Biol Chem 268:22963-22966.
34. Ohmichi M, Pang L, Decker SJ, Saltiel AR. 1992. Nerve growth factor stimulates the activities of the raf-1 and the mitogen-activated protein kinases via the trk protooncogene. J Biol Chem 267:14604-14610.
35. Peraldi P, Frödin M, Barnier JV, Calleja V, Scimeca JC, Filloux C, Calothy G, Van Obberghen E. 1995. Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett 357:290-296.
36. Rattray M. 2001. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol Psychiatry 49:185-193.
37. Siegel GJ, Chauhan NB. 2000. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 33:199-227.
38. Soltoff SP. 1998. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. J Biol Chem 273:23110-23117.
39. Soltoff SP, Avraham H, Avraham S, Cantley LC. 1998. Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 273:2653-2660.
40. Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR. 1994. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 12:691-705.
41. Surprenant A, Buell G, North RA. 1995. P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18:224-229.
42. Swanson KD, Reigh C, Landreth GE. 1998. ATP-stimulated activation of the mitogen-activated protein kinases through ionotrophic P2X2 purinoreceptors in PC12 cells. Difference in purinoreceptor sensitivity in two PC12 cell lines. J Biol Chem 273:19965-19971.
43. Tischler AS, Greene LA. 1975. Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258:341-342.
44. Tischler AS, Greene LA. 1978. Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Lab Invest 39:77-89.
45. Yao H, York RD, Misra-Press A, Carr DW, Stork PJ. 1998. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J Biol Chem 273:8240-8247.